v3.26.1
Cash Equivalents, Restricted Cash Equivalents and Marketable Securities
6 Months Ended
Jun. 30, 2026
Cash and Cash Equivalents [Abstract]  
Cash Equivalents, Restricted Cash Equivalents and Marketable Securities

3. Cash Equivalents, Restricted Cash Equivalents and Marketable Securities

The following tables summarize the amortized cost and fair value of the Company's cash equivalents, restricted cash equivalents and marketable securities by major investment category (in thousands):

 

 

 

As of June 30, 2026

 

 

 

Amortized Cost

 

 

Unrealized Gains

 

 

Unrealized Losses

 

 

Estimated Fair Value

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

2,472

 

 

$

 

 

$

 

 

$

2,472

 

Restricted cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

 

200

 

 

 

 

 

 

 

 

 

200

 

Total cash equivalents and restricted cash equivalents

 

 

2,672

 

 

 

 

 

 

 

 

 

2,672

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasuries and agencies

 

 

38,305

 

 

 

 

 

 

(29

)

 

 

38,276

 

Corporate debt securities

 

 

7,302

 

 

 

 

 

 

(7

)

 

 

7,295

 

Commercial paper

 

 

2,955

 

 

 

 

 

 

(3

)

 

 

2,952

 

Total marketable securities

 

 

48,562

 

 

 

 

 

 

(39

)

 

 

48,523

 

Total cash equivalents, restricted cash equivalents and marketable securities

 

$

51,234

 

 

$

 

 

$

(39

)

 

$

51,195

 

 

 

 

As of December 31, 2025

 

 

 

Amortized Cost

 

 

Unrealized Gains

 

 

Unrealized Losses

 

 

Estimated Fair Value

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

6,757

 

 

$

 

 

$

 

 

$

6,757

 

U.S. Treasuries and agencies

 

 

6,891

 

 

 

 

 

 

 

 

 

6,891

 

Commercial paper

 

 

2,099

 

 

 

 

 

 

 

 

 

2,099

 

Corporate debt securities

 

 

1,491

 

 

 

 

 

 

 

 

 

1,491

 

Total cash equivalents

 

 

17,238

 

 

 

 

 

 

 

 

 

17,238

 

Restricted cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

 

200

 

 

 

 

 

 

 

 

 

200

 

Total cash equivalents and restricted cash equivalents

 

 

17,438

 

 

 

 

 

 

 

 

 

17,438

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasuries and agencies

 

 

25,868

 

 

 

2

 

 

 

(3

)

 

 

25,867

 

Corporate debt securities

 

 

3,233

 

 

 

 

 

 

 

 

 

3,233

 

Commercial paper

 

 

1,991

 

 

 

 

 

 

 

 

 

1,991

 

Total marketable securities

 

 

31,092

 

 

 

2

 

 

 

(3

)

 

 

31,091

 

Total cash equivalents, restricted cash equivalents and marketable securities

 

$

48,530

 

 

$

2

 

 

$

(3

)

 

$

48,529

 

 

All marketable securities are classified as short-term. The Company regularly reviews its available-for-sale marketable securities in an unrealized loss position and evaluates the current expected credit loss by considering factors such as historical experience, market data, issuer-specific factors, and current economic conditions. As of June 30, 2026, the aggregate difference between the amortized cost and fair value of each security in an unrealized loss position was de minimis. Since any provision for expected credit losses for a security held is limited to the amount the fair value is less than its amortized cost, no allowance for expected credit loss was deemed necessary at June 30, 2026. As of June 30, 2026 and December 31, 2025, interest income receivable recorded as a component of prepaid expenses and other current assets on the condensed consolidated balance sheet were $0.2 million and de minimis, respectively.